GB2134117A - Protein composition - Google Patents
Protein composition Download PDFInfo
- Publication number
- GB2134117A GB2134117A GB08401387A GB8401387A GB2134117A GB 2134117 A GB2134117 A GB 2134117A GB 08401387 A GB08401387 A GB 08401387A GB 8401387 A GB8401387 A GB 8401387A GB 2134117 A GB2134117 A GB 2134117A
- Authority
- GB
- United Kingdom
- Prior art keywords
- protein
- solution according
- clupeine
- foam
- acidic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 title description 57
- 108090000623 proteins and genes Proteins 0.000 title description 57
- 239000000203 mixture Substances 0.000 title description 19
- 239000000243 solution Substances 0.000 claims abstract description 74
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 41
- 101800000263 Acidic protein Proteins 0.000 claims abstract description 37
- 239000000839 emulsion Substances 0.000 claims abstract description 15
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- 108010040512 Clupeine Proteins 0.000 claims description 66
- 239000006260 foam Substances 0.000 claims description 58
- 239000012460 protein solution Substances 0.000 claims description 21
- 229960000274 lysozyme Drugs 0.000 claims description 16
- 239000004325 lysozyme Substances 0.000 claims description 16
- 102000016943 Muramidase Human genes 0.000 claims description 15
- 108010014251 Muramidase Proteins 0.000 claims description 15
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 15
- 235000010335 lysozyme Nutrition 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 235000000346 sugar Nutrition 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 6
- 230000000269 nucleophilic effect Effects 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 108050004114 Monellin Proteins 0.000 claims description 3
- 150000001718 carbodiimides Chemical class 0.000 claims description 3
- 239000000892 thaumatin Substances 0.000 claims description 3
- 235000010436 thaumatin Nutrition 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000003473 lipid group Chemical group 0.000 claims 1
- 239000012071 phase Substances 0.000 claims 1
- 238000005187 foaming Methods 0.000 abstract description 14
- 230000002378 acidificating effect Effects 0.000 abstract description 8
- 235000015145 nougat Nutrition 0.000 abstract description 5
- 235000018102 proteins Nutrition 0.000 description 56
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 36
- 229940098773 bovine serum albumin Drugs 0.000 description 36
- 235000013601 eggs Nutrition 0.000 description 32
- 229930006000 Sucrose Natural products 0.000 description 25
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 25
- 239000005720 sucrose Substances 0.000 description 25
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 20
- 239000000499 gel Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 108010058846 Ovalbumin Proteins 0.000 description 16
- 229940092253 ovalbumin Drugs 0.000 description 16
- 210000002381 plasma Anatomy 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 239000003925 fat Substances 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 12
- 102000035118 modified proteins Human genes 0.000 description 11
- 108091005573 modified proteins Proteins 0.000 description 11
- 102000007544 Whey Proteins Human genes 0.000 description 10
- 108010046377 Whey Proteins Proteins 0.000 description 10
- 239000000470 constituent Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000001879 gelation Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 235000021119 whey protein Nutrition 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 244000299461 Theobroma cacao Species 0.000 description 5
- 235000009470 Theobroma cacao Nutrition 0.000 description 5
- 235000020303 café frappé Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- KQSSATDQUYCRGS-UHFFFAOYSA-N methyl glycinate Chemical group COC(=O)CN KQSSATDQUYCRGS-UHFFFAOYSA-N 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- ZDLDXNCMJBOYJV-YFKPBYRVSA-N L-arginine, methyl ester Chemical compound COC(=O)[C@@H](N)CCCN=C(N)N ZDLDXNCMJBOYJV-YFKPBYRVSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000002569 water oil cream Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 108010026206 Conalbumin Proteins 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- -1 amino acid ester Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 150000002337 glycosamines Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 101000889976 Arabidopsis thaliana Myb family transcription factor APL Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 208000035859 Drug effect increased Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000012839 cake mixes Nutrition 0.000 description 1
- VPKDCDLSJZCGKE-UHFFFAOYSA-N carbodiimide group Chemical group N=C=N VPKDCDLSJZCGKE-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D13/00—Finished or partly finished bakery products
- A21D13/50—Solidified foamed products, e.g. meringues
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
An aqueous solution contains both acidic and basic proteins and gives better foaming, gelling and emulsion properties than solutions of acidic proteins alone. The basic protein may be made by modifying an acidic protein. Improved aerated products such as meringues and nougat may be made using the solutions.
Description
SPECIFICATION
Protein product
This invention relates to aqueous solutions containing proteins which are capable of forming foams, gels and/or emulsions.
Protein foams may be obtained by whipping an aqueous solution of a protein. The whipping process comprises agitating the solution in the presence of air so that a foam consisting of air cells surrounded by the solution is formed. The function of the protein in these foams is to form a cohesive film or skin around the air cells to prevent the foam collapsing when whipping is stopped. The solution may contain other constituents such as sugar. Such foams are used for a variety of culinary purposes, such as the making of meringues in which the protein foam containing sugar is baked to produce a mass of air cells enclosed by solid walls of protein and sugar. The protein solution is commonly obtained from white of egg but many other sources of protein may be used.
I ne toam-tormi g capacity ot a protein solution, as measured by the increase in volume of the solution on whipping, and also the stability on standing of the foam depends in part on the identity of the protein used. For example a solution of egg albumen gives a reasonable degree of expansion on whipping and the foam formed may be stored for a considerable time before collapsing but a solution of ovalbumin or ovotransferrin without other dissolved constituents gives very limited expansion and poor foam stability.
The expansion on whipping and stability of the foam are affected by other constituents dissolved or dispersed in the protein solution. For example the presence of sucrose may increase both expansion on whipping and foam stability but the presence of even small quantities of lipids such as vegetable oils and fats generally suppresses foam formation either partially or completely. It has therefore been difficult to provide a satisfactory protein foam containing oils or fats and when making a protein foam it has been essential to avoid contamination of the solution by lipids, including contamination by yolk of egg.
Aqueous solutions of proteins may also be used to form protein gels which are a constituent of many manufactured foodstuffs. A protein solution may be converted to a gel on heating but a minimum concentration of protein in the solution is generally required to obtain a firm gel. For many solutions of single proteins the minimum concentration for gelling is about 5 9/100 ml.
Aquous protein solutions are also used to form emulsions with oil phases. Such emulsions are used in manufactured foodstuffs such as mayonnaises and sauces. It is generally desirable that such emulsions should be stable on storage for long periods, however it is found that solutions of many proteins give emulsions which separate on storage for quite short periods.
The proteins used in culinary applications are normally acidic proteins, that is they have isoelectric points less than 7. The acidic proteins include ovalbumin, bovine serum albumin, bovine plasma, whey protein isolates and hydrolysed soya isolates.
It has now been found that the degree of foaming which may be obtained from protein solutions and also the stability of the foams obtained can be greatly improved, even in the presence of large amounts of lipids, by using a combination of basic and acidic proteins in the solution. it has also been found that a protein solution containing both acidic and basic proteins shows improved gelling behaviour on heating in that a lower concentration of protein is required to produce a firm gel, and that an emulsion formed from the protein solution and an oil phase is more stable than a similar emulsion in which only acidic proteins are present.
According to one aspect of the invention there is provided an aqueous solution containing at least one acidic protein and at least one basic protein dissolved therein.
For the purpose of this patent application an acidic protein is one having an isoelectric point of less than 7 and a basic protein is one having an isoelectric point above 7.
The isoelectric point of the basic protein is preferably at least 9.5.
The molecular weight of the basic protein is preferably at least 1 000 and it may be of the order of 4,500-5,000 or higher. Examples of basic proteins which may be used are clupeine, lysozyme thaumatin and monellin. The acidic protein may be obtained from a wide variety of sources including milk, eggs, blood plasma, legumes, meat and microorganisms.
It is desirable that the pH value of the solution should be such that the acidic protein and the basic protein carry opposite electric charges. A pH value of the order of 5 to 8 is generally suitable. For example the basic proteins clupeine and lysozyme have isoelectric points in excess of 10 and the acidic proteins ovalbumin and bovine serum albumin have isoelectric points of about 4.6 so that at pH 7-8 these types of protein carry opposite charges.Although the scope of the invention is not to be limited by theoretical considerations it is believed that the presence in the solution of proteins having opposite electric charges has the effect of stabilizing and strengthening the walls surrounding the air cells when the solution is whipped into a foam, as well as forming a stronger gel on heating and increasing the stability of an emulsion formed from the solution.
The level of acidic protein required in the solution depends upon the application. A concentration of 0.5 g/l 00 ml or more in the solution is generally suitable for forming a foam. The amount of basic protein required to achieve improved foaming is normally less than that of the acidic protein. A ratio of acidic to basic protein from 100 to 1 to 5 to 1 on a weight basis is usually suitable, the improvement in foam behaviour increasing with the amount of basic protein. It has been found that increasing the amount of basic protein above about 0.05 g/ml gives no further improvement in foaming behaviour when the concentration of acidic protein is 0.5 g/l 00 ml.
The solution may contain dissolved compounds other than proteins and these compounds may have a synergistic effect in further improving the degree of foaming and foam stability of solution.
Synergistic compounds include compounds which can form hydrogen bonds, such as sugars (for example sucrose) and glycerol and also compounds which reduce the surface tension of the solution, such as ethanediol, ethanediol dimethyl ether and dioxan. The hydrogen bonding synergistic compounds typically have a marked effect on foaming behaviour at concentrations of the order of 1-20 g/l 00 ml but compounds which reduce the surface tension show synergistic activity at much lower concentrations, for example 0.5 g/100 ml.
The presence of basic protein together with acidic protein in the solution allows stable foams to be formed even in the presence of substantial amounts of lipids. Amounts of oils such as corn oil up to 10% by volume of the solution, or even more, can be added and a stable foam is still obtained. This feature allows satisfactory foams to be obtained from solutions which are contaminated with lipid-containing materials such as egg yolk and also allows the making of foams which contain oils or fats as deliberate constituents. A wide range of aerated food products can thus be obtained. One type of food product which may be made from protein solutions is a meringue, which is made by foaming a protein solution, mixing the foam with sugar and baking the mixture. The mixture may contain fat and other constituents such as cocoa.It is found that protein solutions according to the invention produce meringues which have a lower density, before and after baking, than meringues made using solutions of entirely acidic proteins.
Another food product is nougat, obtained by beating a mixture of a protein solution and a sugar syrup to aerate the mixture followed by addition of further syrup and fat. The use of a protein solution according to the invention allows a nougat of satisfactory density to be obtained using a much smaller amount of protein.
In order to foam a firm gel on heating, that is a gel which does not flow under its own weight, a solution of a protein requires a protein concentration which is above a minimum and for many acidic proteins this minimum concentration is of the order of 5% by weight. This minimum concentration is greatly reduced when a basic protein is present and even when the protein concentration is above that required to give a gel in the absence of basic protein, the addition of basic protein give a gel of increased strength. Good results are obtained when the weight of basic protein present is at least 10% of the weight of acidic protein although improved gelling behaviour may be obtained with a lower content of basic protein.Typically, a solution of an acidic protein will form a gel on heating for 10 minutes at 1000(= only at a protein concentration of at least 5% by weight but the presence of a basic protein in the solution, in an amount of 10% of the weight of acidic protein, allows a gel to form at a protein concentration of only 1.5% by weight.
Most common naturally occurring proteins are acidic and in general the basic natural proteins, such as clupeine, lysozyme, thaumatin and monellin are expensive and available commercially in only limited quantities. The basic protein used in the present invention may be obtained by modifying an acidic protein to increase its isoelectric point so that it becomes a basic protein. The acidic protein may be modified to neutralize at least some of the acidic, negatively charged amino acid residues of the protein by attaching a nucleophilic group to the carboxyl group, thus increasing the isoelectric point. The nucleophilic group may contain basic nitrogen and be attached by means of an amide linkage. The group may be provided by a neutral or basic amino acid ester, an aminosugar or ammonium ion.
One method of attaching the nucleophilic group to the carboxyl group comprises reacting the protein with a carbodi-imide and causing the adduct so formed to react with a nucleophilic reagent to displace the carbodi-imide group. The reaction is shown in the following scheme:
In this scheme RCO2H is the acidic protein, R1 and R2 may be hydrogen or organic groups and Xis the nucleophilic group. The carbodi-imide may be 1 -ethyl-3-dimethylaminopropyl carbodi-imide (EDC), reagent HX may be an amino acid ester such as glycine methyl or ethyl ester or arginine methyl ester, an aminosugar such as glucosamine or ammonium ion. The acidic protein may be a readily available protein such as ,B-lactoglobulin, ovalbumin, bovine serum albumin, soya protein and whey isolate.
The reaction may generally be performed in aqueous solution at a pH from 4.0 to 7.5 and at or near ambient temperature. The pH may be adjusted as necessary during the reaction by addition of acid.
Under these mild reaction conditions the protein does not become denatured. When the reaction is complete the modified protein may be recovered by dialysis and freeze-dried for storage.
The basic proteins so obtained may be used in the same way as the natural basic proteins, with the same beneficial results.
Preparations of basic proteins from acidic proteins are described in the following examples, given by way of illustration.
EXAMPLE 1
An acidic commercial whey protein isolate was dissolved in water to a concentration of 2.0%
W/W. The pH of the solution was adjusted to pH 6.0 with hydrochloric acid (0.5M) and glycine ethyl ester was added to a concentration of 5.0% W/W. EDC was added to a concentration of 0.6% W/W and the mixture held at 400C for 8 hours. The reaction was stopped by adjusting to pH 3.0 with glacial acetic acid. The reaction mixture was then dialysed against running tap water for 48 hours and the retentate freeze-dried to produce a modified (basic) protein isolate (M.P.I.).
Amino acid analysis of the modified protein thus produced showed that 25% of the carboxyl groups of the original protein had been modified. The isoelectric points of the modified proteins were predominantly higher than pH 9.5, whereas the original whey protein isolate comprised proteins having isoelectric points of about 5.
EXAMPLE 2
The acidic protein p-lactoglobulin was dissolved in water to a concentration of 1.3% weight/weight. The pH of the solution was adjusted to 4.75 and glycine methyl ester was added to a concentration of 1.33 M. EDC was added to a concentration of 0.40 M and the mixture was held at 250C for 1 hour, the pH being maintained at 4.75 by addition of 0.5 M hydrochloric acid as required.
The product was then dialysed against water for 48 hours and the retentate was freeze-dried to produce a modified protein.
Aminoacid analysis of the modified protein thus produced showed that 74% of the carboxyl groups of the original protein had been modified. The isoelectric point of the modified protein was higher than pH 10, whereas that of the original ,B-lactoglobulin was pH 5.
EXAMPLE 3
The procedure of Example 2 was repeated except that bovine serum albumin was used instead of p-lactoglobulin. The isoelectric point of the modified protein so produced was again greater than pH 10.
EXAMPLE 4
The procedure of Example 2 was repeated except that in different trials the glycine methyl ester was replaced by equivalent molar amounts of glycine ethyl ester, glucosamine, ammonium chloride and arginine methyl ester. In all cases the isoelectric point of the modified protein produced exceeded pH 10.
EXAMPLE 5
The procedure of Example 2 was followed but replacing po-lactoglobulin with a purified whey isolate and the glycine methyl ester with arginine methyl ester. The isoelectric point of the modified protein produced was greater than 10.
The foaming behaviour of protein solutions according to the invention is described by way of illustration in the following Examples 6 to 11.
EXAMPLE 6
Solutions in water containing the dissolved constituents given in Table 1 below were whipped at ambient temperature for 5 minutes in a food mixer (Kenwood Chef Model A 901) operated at 200 revolutions per minute. The initial volume of the solution before whipping and the volume of the foam produced immediately after whipping were measured. The foam was then allowed to stand undisturbed for 30 minutes at ambient temperature and the volume of liquid which had drained from the foam was measured.
The % foam expansion (FE) and % foam liquid stability (FLS) were calculated as follows:
Foam volume FE = - x 100 Initial liquid volume
Initial liquid volume - volume of
FLS = liquid drained x 100
Initial liquid volume
In Table 1 the first and second columns give the result obtained with a solution containing 0.5% of an acidic protein alone, the third and fourth columns with the same solutions but containing 0.05% of clupeine, and the fifth to eight columns with the same solutions containing 10% of sucrose. The pH value of all the solutions was 7.
It can be seen from these results that in all cases the presence of clupeine improved foaming behaviour considerably, although in the cases of egg albumen and ovalbumin the effect was observed only in the presence of sucrose.
EXAMPLE 7
The same procedure as in Example 6 was followed but the solutions had the compositions given in
Table 2. The results given in the table show that the addition of clupeine gave good foaming behaviour even in the presence of oil. In these experiments the pH value of the solution was 8. In Table 2 "BSA" is bovine serum albumin, "oil" is corn oil.
EXAMPLE 8
The procedure of Example 6 was followed using solutions containing 0.5% of ovalbumin with or without 0.05% of clupeine and with the additional constituents given in Table 3. The pH value of the solutions was 8. It can be seen from Table 3 that the hydrogen-bonding compounds sucrose and glycerol and also the surface tension-reducing compound ethanediol had a marked synergistic effect on the foaming behaviour of the solutions.
EXAMPLE 9
In order to investigate the effect of differing amounts of clupeine the procedure of Example 6 was followed using solutions of pH 8 containing 0.5% of ovalbumin and 10% sucrose with the concentrations of clupeine shown in Table 4 present. The results show that the clupeine had a marked effect even in amounts of .005% and the effect increased at higher clupeine amounts. No further improvement was found with concentrations of clupeine above 0.05%.
EXAMPLE 10
The procedure of Example 6 was followed except that 0.1% of lysozyme was used instead of clupeine. The results are shown in Table 5. These results show that lysozyme has a similar effect as clupeine with and without sucrose present.
EXAMPLE 11
The procedure of Example 6 was followed but using solutions of pH 8 containing 0.5% of bovine serum albumin together with the constituents given in Table 6. It will be noted that in all cases the presence of clupeine gave a large improvement in foaming behaviour.
EXAMPLE 12
The procedure of Example 6 was followed but using the constituents shown in Table 7. The oil
used was Mazola vegetable oil and the pH value of the protein solution was 6. The results are shown in
Table 7. It can be seen that 1.0% of oil destroyed the whipping properties of the BSA (bovine serum
albumin) solution but 10% of oil had little effect on the properties of the BSA/clupeine solution. Large
amounts of oil, for example 25%, reduced the foam expansion of the BSA/clupeine system somewhat
but increased the foam stability.
The solutions described above may be foamed in order to produce foamed culinary products of
kinds which are already known, such as meringues, cake mixes and batters. They may also be used in
aerated food products which contain lipids, such as low calory dietary foods, which have not hitherto
been made by a foaming process. Foams made from the protein solutions may also be used for non
culinary purposes, for example as aerated lubricants.
The making of foamed culinary products is described by way of illustration in Examples 13 and 14.
EXAMPLE 13
Preparation of Nougat:
Nougat consists of a frappe of egg white and glucose syrup in which a sugar syrup, fat and sugar
to grain are added.
The standard recipe is as follows:
Ingredient g
Spray dried egg albumen 151 Water 30 Liquid glucose 42DE 125 2 Sucrose 7601 Liquid glucose 42DE 525 3 Water 190 Icing sugar 35 4
(Hydrogenated pal kernel oil) 45
Ingredients 1 were mixed and left to soak for at least two hours. 1 and 2 were then beaten to a stiff foam in a Hobart CE100 mixer for 5 minutes on speed (3). The density of the frappe was measured.
Meanwhile ingredients 3 were mixed, dispersed over a flame for 1 min, then boiled to 270cm. The resultant syrup was slowly poured into the frappe in a thin stream, while mixing on speed (1). The icing sugar and lastly the melted fat were mixed in on speed (1) and the density of the mixture was measured.
The remainder of the mixture was poured into trays lined with rice paper and allowed to grain overnight.
This procedure was repeated with the amounts of egg albumen with and without addition of clupeine and M.P.I., shown in Table 8. The density of the frappe and the final mix are shown in the
Table.
When the total protein content was reduced to about half but a basic protein was included a satisfactory product was obtained with the same density of the standard. When the protein content was reduced to half but a basic protein was not included on unsatisfactory product of greater density was produced. In this example "MPI" is a modified protein isolate made by the method of Example 1.
EXAMPLE 14
Preparation of Meringues:
Standard recipe: 1 50 g protein solutions (pH 7.5)
300 g caster sugar
A Simon Reels Oven was set at 11 50C. Protein solutions were beaten for 6 minutes at top speed in a 5-litre capacity bowl using a Hobart CE 100 mixer fitted with a whisk. Half the caster sugar was added gradually with the mixer at slow speed and then the mix was beaten at top speed for a further 2 minutes. The remaining sugar was gently folded into the mix using a wooden spoon. The mix was poured into a savoy bag and shells were piped out on a metal sheet covered with aluminium foil. The shells were baked for 60 minutes until the outer parts were firmly set. Holes were made in the bases and the meringues dried overnight in a warm oven (balmic at 300C).
The densities (g/1 00 ml) of the meringue mixes and meringues after drying were measured.
Where fat (melted hydrogenated palm kernel oil) was incorporated this was added at the start prior to whipping. When cocoa powder was incorporated this was added with the first part of the caster sugar.
The compositions of the protein solutions used and the densities of the products obtained are shown in
Table 9, in which "MPI" denotes the modified protein isolate of Example 1.
As seen from Table 9, satisfactory meringues which were as light or ligher than the standards were made using only half the normal amount of egg albumen and a small amount of basic protein (clupeine, lysozyme or M.P.I.). Fat (10%) destroyed the whipping proportions of the egg albumen but when M.P.I. was included a meringue was produced which was only slightly denser than the non-fat standard. This demonstrates the ability of the mixed protein system to overcome fat contamination during meringue production. The presence of cocoa powder (which contains fat) in a normal meringue mix resulted in the meringue being very dense. The presence of basic protein (M.P.I.) resulted in a much lighter meringue.
The following examples illustrates the setting behaviour of some solutions containing acidic and basic proteins.
EXAMPLE 1 5
The amount of a protein powder required to give a solution of the desired concentration was calculated from its protein content (nitrogen x factor). Distilled water was stirred vigorously with a magnetic stirrer, creating a vortex, and the powdered protein added siowly. Stirring was continued at a reduced speed for 20 minutes. In the case of plasma, the resulting solution was allowed to stand for one hour to allow the insoluble proteins to settle and the upper soluble layer was decanted off (the amount of insoluble protein was compensated for). All the other protein solutions were used direct.
For solutions containing both acidic protein and clupeine, the two components were dissolved separately at twice the required concentration, then mixed in equal quantities. Where necessary the pH was adjusted using 0.5M hydrochloric acid or sodium hydroxide.
1 2.5 ml samples of the protein/clupeine solutions at the required pH were poured into boiling tubes and heated at the required temperature in a water bath for 20 minutes. After this time the extent of gelation was assessed visually (if on inversion of the tube there was no flow of the solution a gel was considered to have been formed).
The results are shown in Tables 10 to 15.
The behaviour of solutions containing acidic and basic proteins in emulsions is illustrated by the following Example.
EXAMPLE 16
Solutions containing 1 9/100 ml of egg albumen in water and 1 g/l 00 ml plasma protein in water were prepared. The solutions had a pH value of 6. To samples of these solutions were added 0.16 g/100 ml solution of lysozyme. The solutions were emuisified with equal weights of corn oil by simultaneously pouring the solutions and oil into one side of an ultrasonicator (Minisonic 4 of Ultrasonic Ltd.). The mixture was allowed to circulate through the apparatus for 30 seconds, collected and recirculated through the ultrasonicator four times more. The resulting emulsions were allowed to stand undisturbed for one week in the dark. The percentages of oil and water separation were then measured.
The results obtained are shown in Table 1 6.
It can be seen that for both egg white and bovine plasma, the lysozyme improved emulsion stability to a considerable extent.
Similar results were obtained using clupeine instead of lysozyme.
TABLE I
Effect of olupeine with and without sucrose
on protein foam expansion and stability
Distilled Water 10% Sucrose Protein + Protein + a@@@e @@@pen@e a@@@e @@@pen@@ Protein FE FLS FE FLS FE FLS FE FLS Egg albumen 240 19 160 16 440 35 810 76 Ovalbumin 40 10 40 10 120 10 620 23 Bovine serum albumin 340 12 680 54 460 10 800 71 Bovine plasma 260 12 360 30 320 28 800 73 Whey protein isolate 600 23 780 33 620 19 840 48 Soy isolate 500 10 720 68 480 20 760 74 (enzyme hydrolysed) TABLE 2
Effect of clupeine on protein foaming systems containing oil
Consituents FE % FLS % Comments on Foam 0.5K BSA, 10% sucrose 460 10 pourable 0.5% BSA, 10% sucrose 1% ail O O no foam 0.5% BSA, 10% sucrose 1% oil, 0.05% clupeine 720 64 -stiff 1% BSA, 10% sucrose, 5% oil 60 0 no foam 1% BSA, 10% sucrose, 5% oil, 0.1% clupeine 800 81 very good; stiff 0.5% Whey, 10% sucrose 260 5 poor foam 0.5% Whey, 10% sucrose 0.05% clupeine 660 35 good foam TABLE 3
Effect of hydrogen bonding compounds and surface tension reducing compounds
on protein foam expansion stability
System FE % FLS X Comments on Foam Ovalbumin 40 5 very poor Ovalbumin + clupeine 40 @ 5 very poor Ovalbumin + clupeine 620 22.5 very stiff + 10% sucrose Ovalbumin + clupeine 620 29.5 very stiff + 10% glycerol Ovalbumin + 0.5% 40 2 very poor ethanediol Ovalbumin + clupeine 560 26 stiff + 0.5% ethanediol TABLE 4
Effect of increasing clupeine concentration on foam expansion
and foam stability of protein sucrose system*
Clupeine Concentration FE % FLS % 0 40 5 0.005% 300 16 0.010% 520 55 0.015% 700 66 0.025% 720 71 0.05% 640 83 *.AIl systems contained 10% sucrose + 0.5% ovalbumin.
TABLE 5
Effect of lysozyme on protein foam expansion
and stability in the presence and absence of sucrose
Distilled water 10% Sucrose Protein + Protein + alone -Lysozyme alone Lysozyme Protein FE | FLS FE FLS FE FLS FE FLS Bovine serum albumin 280 12 760 69 360 4 880 85 Whey protein isolate 600 21 780 47 620 19 840 69 Egg albumen 240 24 220 26 440 35 800 90 Ovalbumin 40 10 40 10 120 10 760 54 Ovotransferrin! 100 5 100 5 140 7 420 23 Bovine plasma 260 12 360 24 300 14 760 70 Bovine p-globulin 200 5 700 40 NT NT NT NT Fibrinogen 360 12 80 10 360 31 620 52 Sodium caseinate 460 14 540 28 320 17 540 ; 23.5 p-Lactoglobulin 480 12 680 88 NT NT NT NT ! = 0.2% solutions used
NT = not tested
TABLE 6
Effect of clupein on protein foam expansion and stability in the presence of liquid materials
Glycerol Monostearate (monoglyceride) (GMS)
BSA = 0.5%; pH = 8
FE % FLS % Comments BSA + 0.1% GMS only 0 0 no foam BSA + 0.1% GMS + 0.05 clupeine 520 40 reasonable foam Stearic Acid (Free Fatty Acid)
BSA = 0.5% pH = 8 sucrose = 10%
FE % FLS % Comments BSA + 0.1 stearic acid 100 2 poor foam BSA + 0.1 stearic acid + 0.05 clupeine 760 74 very good foam Lecithin (phospholipid)
BSA = 0.5% pH = 8 sucrose = 10%
FE % FLS % Comments 0.02% lecithin 0 0 no foam 0.02% lecithin + 0.02% clupeine | 680 45 good foam TABLE 7
BSA(1.0%) BSA(1.0%)/Clupeine (0.1%) % oil % FE % FLS % FE % FLS 0 664 31 720 47 1.0 100 5 - 5.0 172 4 712 51 10.0 128 4 704 49 20.0 176 7 640 60 25.0 - - 504 64 TABLE 8
Final Mix Frappe Density (g/ml) Protein Quantity (g) Density (g/ml) (Before graining) Egg Albumen 15 0.65 1.25 Egg Albumen 6 0.68 1.23 Clupeine 1.5 Egg Albumen 15 0.65 0.97 Egg Albumen 7.5 0.71 1.38 Egg Albumen 7.5 0.58 0.97 M.P.I. 0.75 TABLE 9
Mix Baked Density Density Protein Quantity (g) (gI100 ml) (9/100 ml) Egg Albumen 18 23.5 12.0 Egg Albumen 9.0 25.6 14.2 Egg Albumen 8.1 20.2 10.1 Lysozyme 0.9 Egg Albumen 8.1 19.8 9.1 Clupeine 0.9 Egg Albumen 18 19.1 9.2 Egg Albumen 9.0 68.7 15.7 Egg Albumen 9.0 52.0 9.2 M.P.I. 0.9 Egg Albumen 18.0 NO FOAM AFTER (+ 1% Fat) NORMAL WHIPPING TIME (6 min.) Egg Albumen 9.0 69.2 13.6 M.P.I. (+ 1% Fat) 0.9 Egg Albumen 18.0 47.5 17.5 (+ 3% cocoa powder) Egg Albumen 9.0 66.0 12.6 M.P.I. (+ 3% cocoa powder) 0.9 TABLE 10
The effects of clupeine and pH on the gelation of BSA and Plasma
(950 C. 20 min.)
I < pH 4,0 | 5.0 | 6.0 7.0 8.0 | 9.0 10.0 System \ 2% BSA X A1 X X X X 2% BSA + 0.2% Clupeine A/ ,/' V' '/, x 2% Plasma X + X X X X X 2% Plasma + 0.2% Clupeine X V V V V V x # - Gel Formed. X - Gel Not Formed.
TABLE 11
Effect of Clupeine Concentration on Gelation of BSA (pH 8, 950C, 20 min.)
System Gelation 3% ESA X 3% BSA + 0.1% Clupeine X 3% BSA + 0.2% Clupeine X 3% BSA + 0.3% Clupeine V 1% BSA + 0.5% Clupeine X 1% BSA + 0.1% Clupeine # TABLE 12
Gelation of Plasma (pH 8, 950C, 20 mins)
Plasma Plasma + Clupeine Concn (%) Plasma alone 10::1 Ratio 5 # # 4 # # 4 (Dialysed) X 3 ss X V 2 X # 1.5 X V 1.0 X X Not Tested
TABLE 13
Effect of Clupeine on the gel strength of plasma gels
Sucrose Break Increase in Plasma Temp. Clupeine Conc. % point gel strength Conc. % OC. Conc. % (w/v) (9) with Clupeine 7.5 90 0 0 124 7.5 90 0.7 0 144 16 5.0 90 0 0 50 5.0 90 0.5 0 51 2 7.5 80 0 0 136 7.5 80 0.7 0 180 17 7.5 90 0 20 118 7.5 90 0.7 20 132 12 5.0 90 0 20 23 5.0 go 0.5 20 33 43 TABLE 14
System Gelation 5% Bipro X 5% Bipro + 0.1% Clupeine X 5% Bipro + 0.2% Clupeine X 5% Bipro + 0.3% Clupeine X 5% Bipro + 0.4% Clupeine # 5% Bipro + 0.5% Clupeine X 3% Bipro + 0.1% Clupeine # 3% Bipro + 0.2% Clupeine # 3% Bipro + 0.3% Clupeine X Bipro is a whey protein isolate. TABLE 15
Effect of Clupeine on Gelation of Egg Albumen (pH 8, 95 C). 20 min.
System Gelation 5% Egg Albumen # 4% Egg Albumen # 3% Egg Albumen X 2% Egg Albumen X 5% E.A. + 0.5% Clupeine # 4% E.A. + 0.4% Clupeine # 3% E.A. + 0.3% Clupeine # 2% E.A. + 0.2% Clupeine # 1% E.A. + 0.1% Clupeine X TABLE 16
Separation of protein-oil water emulsions after storage for 1 week at ambient temperature
Egg White Egg White + Lysozyme Plasma Plasma + Lysozyme % % % % % % % % % % % % Oil Emulsion Water Oil Emulsion Water Oil Emulsion Water Oil Emulsion Water 3 66 31 - 82 18 2 67 31 - 88 12
Claims (17)
1. An aqueous solution containing at least one acidic protein and at least one basic protein dissolved therein.
2. A solution according to claim 1, in which the basic protein has an isoelectric point of at least 9.5.
3. A solution according to claim 1 or 2, in which the molecuiar weight of the basic protein is at least 1000.
4. A solution according to any preceding claim, in which the ratio of the concentration of acidic protein to the concentration of basic protein by weight is from 100:1 to 5:1.
5. A solution according to any preceding claim, in which the basic protein is selected from clupeine, lysozyme, thaumatin and monellin.
6. A solution according to any one of claims 1 to 4, in which the basic protein comprises an acidic protein which has been modified to increase its isoelectric point.
7. A solution according to claim 6, in which the basic protein comprises an acidic protein to the carboxyl group of which a nucleophilic group has been attached.
8. A solution according to claim 7, in which the basic protein comprises an acidic protein which has been caused to react with a carbodi-imide followed by reaction with a nucleophilic agent.
9. A solution according to any preceding claim, which contains at least one compound capable of forming hydrogen bonds.
10. A solution according to claim 9, which contains at least one sugar.
11. A solution according to any preceding claim, containing at least one compound capable of reducing the surface tension of protein solutions.
12. A foam, comprising an aerated solution according to any preceding claim.
13. A foam according to claim 12, containing at least one lipid.
14. An aerated edible product, obtained from a foam according to claim 12 or 1 3.
1 5. A gel, obtained by heating a solution according to any one of claims 1 to 11.
16. An emulsion, formed of an aqueous phase comprising a solution according to any one of claims 1 to 11 and an oil phase.
17. An aqueous solution according to claim 1, substantially as hereinbefore described with reference to the foregoing Examples.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08401387A GB2134117B (en) | 1983-01-21 | 1984-01-19 | Protein composition |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838301764A GB8301764D0 (en) | 1983-01-21 | 1983-01-21 | Protein product |
| GB838301765A GB8301765D0 (en) | 1983-01-21 | 1983-01-21 | Protein emulsions |
| GB838309883A GB8309883D0 (en) | 1983-04-12 | 1983-04-12 | Protein product |
| GB08401387A GB2134117B (en) | 1983-01-21 | 1984-01-19 | Protein composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8401387D0 GB8401387D0 (en) | 1984-02-22 |
| GB2134117A true GB2134117A (en) | 1984-08-08 |
| GB2134117B GB2134117B (en) | 1986-05-29 |
Family
ID=27449437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08401387A Expired GB2134117B (en) | 1983-01-21 | 1984-01-19 | Protein composition |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2134117B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000038547A1 (en) * | 1998-12-23 | 2000-07-06 | Unilever N.V. | Food product comprising gas bubbles |
| WO2004028281A1 (en) * | 2002-09-27 | 2004-04-08 | Nestec S.A., A Swiss Body Corporate Of Avenue Nestle 55 | Interface stabilisation of a product with 2 or more phases with a protein-polysaccharide complex |
| EP2086355A4 (en) * | 2006-11-03 | 2010-06-23 | Tfh Publications Inc | NUTRITIONAL SUPPLEMENT |
| US20210289811A1 (en) * | 2014-05-28 | 2021-09-23 | Amano Enzyme Inc. | Highly emulsifiable albumen hydrolysate |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012505645A (en) | 2008-10-16 | 2012-03-08 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Hydrophobin solution containing defoamer |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1334397A (en) * | 1971-01-26 | 1973-10-17 | Wolfen Filmfab Veb | Gelatin composition |
-
1984
- 1984-01-19 GB GB08401387A patent/GB2134117B/en not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1334397A (en) * | 1971-01-26 | 1973-10-17 | Wolfen Filmfab Veb | Gelatin composition |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000038547A1 (en) * | 1998-12-23 | 2000-07-06 | Unilever N.V. | Food product comprising gas bubbles |
| AU743555B2 (en) * | 1998-12-23 | 2002-01-31 | Unilever Plc | Food product comprising gas bubbles |
| US6579557B1 (en) | 1998-12-23 | 2003-06-17 | Lipton, Division Of Conopco, Inc. | Food product comprising gas bubbles |
| WO2004028281A1 (en) * | 2002-09-27 | 2004-04-08 | Nestec S.A., A Swiss Body Corporate Of Avenue Nestle 55 | Interface stabilisation of a product with 2 or more phases with a protein-polysaccharide complex |
| EP1402790A3 (en) * | 2002-09-27 | 2004-05-06 | Nestec S.A. | Interface stabilisation of a product with 2 or more phases with a protein-polysaccharide complex |
| CN1323616C (en) * | 2002-09-27 | 2007-07-04 | 雀巢技术公司 | Interface stabilization of a product with two or more phases with a protein-polysaccharide complex |
| EP2086355A4 (en) * | 2006-11-03 | 2010-06-23 | Tfh Publications Inc | NUTRITIONAL SUPPLEMENT |
| US20210289811A1 (en) * | 2014-05-28 | 2021-09-23 | Amano Enzyme Inc. | Highly emulsifiable albumen hydrolysate |
| US12599150B2 (en) * | 2014-05-28 | 2026-04-14 | Amano Enzyme Inc. | Highly emulsifiable albumen hydrolysate |
Also Published As
| Publication number | Publication date |
|---|---|
| GB8401387D0 (en) | 1984-02-22 |
| GB2134117B (en) | 1986-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4572837A (en) | Protein product | |
| EP0327120B1 (en) | Process for producing rolled-in type emulsified fat and oil composition | |
| EP0402090B1 (en) | Edible oil-in water emulsion | |
| EP0037447B1 (en) | Acid-resisting whipping cream powder and process for producing the same | |
| US4650690A (en) | Edible water-in-oil-in-water emulsion | |
| US4861610A (en) | Process for preparing emulsified fat composition containing cheese | |
| IE41943B1 (en) | Stabilised emulsions comprising phospholip-protein | |
| BR0012257B1 (en) | ACID EMULSIFIED OIL-IN-WATER COMPOSITION | |
| US3712865A (en) | Edible oil emulsions | |
| EP0032808B1 (en) | Plastic fat-based material and products therefrom | |
| JPS63185350A (en) | Emulsification of fats of oils in aqueous phase consisting essentially of soy sauce | |
| WO2003088759A1 (en) | Flavour-enhanced food product | |
| JPH1156283A (en) | Composition for whipped cream | |
| GB2134117A (en) | Protein composition | |
| US5194282A (en) | Food products having a reduced fat content | |
| US3030211A (en) | Food products containing deamidized gliadin | |
| GB2061692A (en) | Powdered compositions for cream toppings | |
| EP0163787A1 (en) | Protein product | |
| JP2003134998A (en) | Oil-in-water emulsion for kneading pudding | |
| Garti | Food emulsifiers and stabilizers | |
| JP3112552B2 (en) | Oil-in-water emulsion, powder and whipped cream | |
| JP3113042B2 (en) | Production method of oil-in-water emulsion | |
| JPH093479A (en) | Oil and fat emulsified composition and method for producing the same | |
| WO2000011973A1 (en) | Spray-dried emulsified topping base | |
| JP2568462B2 (en) | Oil composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee | ||
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930119 |